Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-019-04385-6
Abstract: PurposeProstate-specific membrane antigen (PSMA) PET/CT is increasingly used in patients with biochemically recurrent prostate cancer (BCR), mostly using gallium-68 (168Ga)-labelled radiotracers. Alternatively, fluorine-18 (18F)-labelled PSMA tracers are available, such as 18F-DCFPyL, which offer enhanced image… read more here.
Keywords: cancer; 18f dcfpyl; dcfpyl pet; detection ... See more keywords
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Nuclear Medicine"
DOI: 10.1007/s12149-017-1201-4
Abstract: ObjectiveRadiotracers targeting prostate-specific membrane antigen (PSMA) have increasingly been recognized as showing uptake in a number of normal structures, anatomic variants, and non-prostate-cancer pathologies. We aimed to explore the frequency and degree of uptake in… read more here.
Keywords: ganglia; 18f dcfpyl; prostate specific; psma targeted ... See more keywords
The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2020.08.014
Abstract: Purpose Our purpose was to study the effect of 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (18F-DCFPyL) positron emission tomography (PET)-computed tomography (CT) on staging/treatment recommendations of previously untreated prostate cancer. We report here results of a prospective single center… read more here.
Keywords: pet; 18f dcfpyl; treatment; treatment recommendations ... See more keywords
PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework
Sign Up to like & getrecommendations! Published in 2019 at "Urology Case Reports"
DOI: 10.1016/j.eucr.2019.01.007
Abstract: We present the case of a man with oligometastatic prostate cancer who underwent a PSMA-targeted 18F-DCFPyL PET/CT scan in order to illustrate how the PSMA-RADS grading sytem can be successfully used to support clinical decision-making… read more here.
Keywords: 18f dcfpyl; prostate cancer; targeted 18f; psma targeted ... See more keywords
[18F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience.
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2016.10.002
Abstract: An ongoing prospective study is acquiring preoperative imaging data for men with prostate cancer (PCa) using the molecular imaging agent [18F]-DCFPyL targeted against prostate-specific membrane antigen (PSMA). To date, six men (of a planned accrual… read more here.
Keywords: prostate; 18f dcfpyl; pathology; positron emission ... See more keywords
Prostate Cancer Local Recurrence Detected With Both 18F-Fluciclovine and PSMA-targeted 18F-DCFPyL PET/CT.
Sign Up to like & getrecommendations! Published in 2017 at "Urology"
DOI: 10.1016/j.urology.2017.06.015
Abstract: We present the case of a 79-year-old man with an elevated postprostatectomy prostate-specific antigen level who was sequentially imaged with positron emission tomography/computed tomography (PET/CT) using 18F-fluciclovine followed by PSMA-targeted 18F-DCFPyL. Although both imaging tests… read more here.
Keywords: prostate; 18f dcfpyl; prostate cancer; targeted 18f ... See more keywords
Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2081155
Abstract: ABSTRACT Introduction Accurate imaging is essential for staging prostate cancer and guiding management decisions. Conventional imaging modalities are hampered by a limited sensitivity for metastatic disease. Nearly all prostate cancers express prostate-specific membrane antigen (PSMA)… read more here.
Keywords: prostate cancer; pet; psma; 18f dcfpyl ... See more keywords
Physiologic prostate-specific membrane antigen-targeted 18F-DCFPyL uptake in the epididymis head newly appreciated on digital PET/CT.
Sign Up to like & getrecommendations! Published in 2020 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001363
Abstract: The published physiological distribution of prostate-specific membrane antigen (PSMA) PET ligands includes normal uptake in the lacrimal glands, salivary glands, bowel, liver, spleen, kidneys and parasympathetic ganglia but does not include the epididymis. Using a… read more here.
Keywords: prostate specific; specific membrane; digital pet; 18f dcfpyl ... See more keywords
Prospective intraindividual comparison of 18F-PSMA-7Q and 18F-DCFPyL PET/CT in patients with newly diagnosed prostate cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Nuclear medicine communications"
DOI: 10.1097/mnm.0000000000001564
Abstract: OBJECTIVE Fluorine 18 (18F)-2-(3-{1-Carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (DCFPyL) is an early 18F-labeled prostate-specific membrane antigen (PSMA) targeted PET tracer that has shown promise in the diagnostic workup of prostate cancer and was recently approved by the US… read more here.
Keywords: 18f psma; prostate cancer; psma; 18f dcfpyl ... See more keywords
Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18F-DCFPyl PET/CT.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004554
Abstract: ABSTRACT 18F-DCFPyl is a Food and Drug Administration-approved radiotracer that targets prostate-specific membrane antigen and is used in the detection of recurrent or metastatic prostate cancer. As its use has increased, a growing number of… read more here.
Keywords: prostate cancer; hepatic small; small vessel; 18f dcfpyl ... See more keywords
Incidental Adiposis Dolorosa (Dercum's Disease) Detected on 18F-DCFPyL PET/CT.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004600
Abstract: ABSTRACT A 64-year-old man with recently diagnosed prostate adenocarcinoma and Gleason score 4 + 3 = 7 with a mildly elevated prostate-specific antigen of 5.17 μg/L was referred for 18F-DCFPyL PET/CT for primary staging. The… read more here.
Keywords: disease; dolorosa dercum; adiposis dolorosa; dcfpyl pet ... See more keywords